Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Fungal Meningitis Symptoms May Take Weeks To Appear, CDC Warns October 12, 2012 Irvin Jackson Add Your Comments The number of people sickened or killed from a fungal meningitis outbreak caused by tainted drugs is expected to keep climbing, due to the long latency period of the illness and difficulty testing for the infection.  The injections, manufactured and distributed by the New England Compounding Center (NECC), were reportedly distributed between May 2012 and the end of September 2012. It can take a month or more for symptoms of fungal meningitis to appear, meaning that there may be people who received contaminated epidural steroid injections who do not get sick until late October or early November 2012. Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The CDC estimates that about 14,000 people received shots directly to the spine for pain relief that may have been contaminated. Originally, the CDC said about 13,000 people received the shots, but increased that estimate on October 11. More Than 170 Diagnosed With Fungal Meningitis As of Friday morning, the U.S. Centers for Disease Control and Prevention (CDC) reports that at least 14 people have died and 170 have fallen ill as a result of New England Compounding Center’s recalled epidural steroid injections. However, a substantial number of people are currently receiving treatment for symptoms of meningitis and awaiting test results. In addition to the delayed onset of symptoms after exposure, federal health officials indicate that many cases may also be missed because tests used to check for fungal meningitis are not always accurate. Fungal meningitis is a non-contageous form of meningitis caused by mold that somehow tainted vials of the epidural injections. It causes inflammation of the spinal cord and protective membranes covering the brain. The inflammation generally causes an infection of the fluid surrounding the brain and spinal cord and can also be caused by parasites, viruses and bacterial infection. Individuals with a weakened immune system may be at a particularly high risk of contracting fungal meningitis. Symptoms of meningitis following an epidural steroid injection may include fever, headache, stiff neck, nausea, vomiting, increased sensitivity to light and mental confusion. Signs of meningitis usually develop within three to seven days after exposure. As the disease progresses, symptoms may become severe, resulting in seizures, coma and death. Second Pharmacy Shuts Down Amid Calls for Criminal Probe While the outbreak and initial recall were only linked to three lots of methylprednisolone acetate, New England Compounding Center has shut down all of its operations over concerns about its manufacturing process. On Wednesday, a second Massachusetts compounding pharmacy, Ameridose, also shut down, raising concerns about the safety of medications mixed by the facility. Ameridose and New England Compounding Center have the same principal owners. However, company officials indicate that they do not share manufacturing, distribution or storage facilities or practices. No drugs from Ameridose have been linked to the outbreak The developments came as anger began to rise over the outbreak and what appears to have been a gross overstepping of New England Compounding Center’s license with the state of Massachusetts. Compounding pharmacies are supposed to fill critical drug needs for local health care facilities when drug manufacturers cannot. They generally step in to fill drug shortages or to create specialty drugs for specific patients. State officials say that appears to have not been the case with New England Compounding Center and accuse the company of being a stealth large-scale drug manufacturer. Massachusetts Governor Deval Patrick suggested the pharmacy may have intentionally misled regulators about the type of work being done there. New England Compounding Center was able to create and distribute drugs cheaper and faster than recognized drug manufacturers because compounding pharmacies have few regulations and little FDA oversight. Acknowledged drug companies, however, have to get FDA approval to develop and sell drugs. They also have restrictions on how those drugs are marketed. U.S. Senator Richard Blumenthal, from Connecticut, has called for a federal criminal probe into New England Compounding Center. He says he does not know if the company broke any laws, but believes there are enough credible allegations to send the Justice Department into action. Not the First Time New England Compounding Center Accused of Bad Drugs The fungal meningitis outbreak is not the first time New England Compounding Center has faced legal problems over potentially contaminated drugs. In 2006, the company reached a settlement in a wrongful death lawsuit brought by the family of William Koch, who received a shot in 2002, which the family said was contaminated. He died of bacterial meningitis in 2004. Details of the settlement remain confidential. As a result of this most recent outbreak, New England Compounding Center is expected to face substantial liability from contaminated epidural injection lawsuits filed by individuals diagnosed with fungal meningitis. However, it is unclear how much insurance coverage is available or what assets may be available to cover any judgement or settlements. Tags: Hospital Infection, Infection, Massachusetts, Meningitis, Pharmacy, Pharmacy Error Image Credit: | More Lawsuit Stories Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials April 2, 2025 Nitrous Oxide Class Action Lawsuit Filed Over Fatal Side Effects of Flavored Gas Sold In Vape Shops April 2, 2025 Artificial Stone Cutter Files Lawsuit Over Silicosis Lung Disease April 2, 2025 2 Comments Robin October 14, 2012 It is my understanding that *if your injection was a trigger point injection w/steroids you are in NO DANGER! Is that true? (or should I contact my doctor?) Wes October 17, 2012 I was given a trigger point injection at the end of July. I received a call from the center that did my injection and they told me that I needed to seek medical attention ASAP! I’ve had the headaches, stiff neck, dizziness and at times, very nauseated. After worrying about this whole thing, I was on the table and ready for the spinal tap. My doctor made a call to the physician that gave me the injection and that physician told my doctor that my shot was NOT in the spine and was given in the muscle. I was told that I could leave and there was no reason for the spinal tap. First, why did the clinic have me worried when they knew that I had a trigger point injection if it was nothing to worry about? Second, why do I have several of the signs of the infection? Third, my shot WAS infected and they admitted to that, so what happened to the fungus? Could I be infected even if my shot was not directly injected into my spine? I’m worried sick about this whole thing and I still have NO ANSWERS!! Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: today) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025) Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: yesterday) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025) Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: 2 days ago) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)
Nitrous Oxide Class Action Lawsuit Filed Over Fatal Side Effects of Flavored Gas Sold In Vape Shops April 2, 2025
Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: today) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025)
Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: yesterday) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)
Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: 2 days ago) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)